OVID Ovid Therapeutics
- 3.200
- +0.090+2.89%
Ovid Therapeutics News
Ovid Therapeutics | 8-K: Current report
Ovid Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Ovid Therapeutics | 10-Q: Quarterly report
Ovid Therapeutics | 8-K: Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
Ovid Therapeutics | ARS: Annual Report to Security Holders
Ovid Therapeutics | DEFA14A: Others
Ovid Therapeutics | DEF 14A: Definitive information statements
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEVIN JEREMY M
Ovid Therapeutics | 10-K: Annual report
Ovid Therapeutics | 8-K: Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Tardio Jason
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rona Jeffrey A
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Poole Robert Michael
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Perone Thomas Michael
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEVIN JEREMY M
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Friedman Bart
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fitzgerald Kevin Joseph
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Duncan Barbara Gayle
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bernstein Karen
Ovid Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jeremy M. Levin(9.4%)
Analysis
Price Target
No Data
